Ultrabright pulses produced in X-ray free-electron lasers (XFELs) offer new possibilities for industry and research, particularly for biochemistry and pharmaceuticals. The unprecedented brilliance of these next-generation sources enables structure determination from sub-micron crystals as well as radiation-sensitive proteins. The European X-Ray Free-Electron Laser (EuXFEL), with its first light in 2017, ushered in a new era for ultrabright X-ray sources by providing an unparalleled megahertz-pulse repetition rate, with orders of magnitude more pulses per second than previous XFEL sources. This rapid pulse frequency has significant implications for structure determination; not only will data collection be faster (resulting in more structures per unit time), but experiments requiring large quantities of data, such as time-resolved structures, become feasible in a reasonable amount of experimental time. Early experiments at the SPB/SFX instrument of the EuXFEL demonstrate how such closely-spaced pulses can be successfully implemented in otherwise challenging experiments, such as time-resolved studies.<p></p>
Funding
In addition to the baseline funding provided by the European XFEL members, we acknowledge funding of instrumentation and staff by the following sources: the Wellcome Trust, the German Federal Ministry for Education and Research (BMBF) via projects 05K13GU7 and 05E13GU1, the Ministry of Education, Science, Research and Sport of the Slovak Republic, The Swedish Research Council (822-2013-2014), the Knut and Alice Wallenberg Foundation, the Rontgen-Angstrom Cluster, the Swedish Foundation for Strategic Research, the Australian Research Council Center of Excellence in Advanced Molecular Imaging (CE140100011), the Australian Nuclear Science and Technology Organisation (ANSTO), the Max Planck Society for Medical Research, the NSF-STC 'BioXFEL' through award STC-1231306, and the Helmholtz Association Strategic Investment funds.